MicroRNAs in the P53 Network: Micromanagement of Tumour Suppression

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2012 Aug 18

PMID 22898542

Citations 301

Authors

Heiko Hermeking

Affiliations

Soon will be listed here.

Abstract

In recent years, microRNAs (miRNAs) have been identified as mediators of tumour suppression and stress responses exerted by the p53 tumour suppressor. p53-regulated miRNAs contribute to tumour suppression by controlling the expression of central components of multiple processes, including cell cycle progression, epithelial-mesenchymal transition, stemness, metabolism, cell survival and angiogenesis. The expression and activity of p53 itself is also under the control of miRNAs. Finally, genetic and epigenetic alterations identified in the p53-miRNA network indicate that these pathways are important for the initiation and progression of tumours. In the future, knowledge about the p53-miRNA network may be able to be exploited for diagnostic and therapeutic approaches in cancer prevention and treatment.

Citing Articles

Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case report.

Kimura T, Sakata K, Ohga N, Sato J, Itagaki T, Munekata T Oncol Lett. 2024; 29(1):52.

PMID: 39564374 PMC: 11574702. DOI: 10.3892/ol.2024.14798.

Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.

Konig J, Rokavec M, Oner-Ziegler M, Fei Y, Hermeking H Cell Death Differ. 2024; 32(2):225-241.

PMID: 39425000 PMC: 11802797. DOI: 10.1038/s41418-024-01380-9.

Mechanistic Insights on Microbiota-Mediated Development and Progression of Esophageal Cancer.

Moe K, Tan K Cancers (Basel). 2024; 16(19).

PMID: 39409925 PMC: 11475040. DOI: 10.3390/cancers16193305.

Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage.

Zerbib J, Ippolito M, Eliezer Y, De Feudis G, Reuveni E, Savir Kadmon A Nat Commun. 2024; 15(1):7772.

PMID: 39251587 PMC: 11385192. DOI: 10.1038/s41467-024-52176-x.

Elucidating microRNA-34a organisation within human Argonaute-2 by dynamic nuclear polarisation-enhanced magic angle spinning NMR.

Dasgupta R, Becker W, Petzold K Nucleic Acids Res. 2024; 52(19):11995-12004.

PMID: 39228364 PMC: 11514488. DOI: 10.1093/nar/gkae744.

References

Koppenol W, Bounds P, Dang C . Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011; 11(5):325-37. DOI: 10.1038/nrc3038. View

Hwang C, Matoso A, Corney D, Flesken-Nikitin A, Korner S, Wang W . Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A. 2011; 108(34):14240-5. PMC: 3161601. DOI: 10.1073/pnas.1017536108. View

Tay Y, Kats L, Salmena L, Weiss D, Tan S, Ala U . Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011; 147(2):344-57. PMC: 3235920. DOI: 10.1016/j.cell.2011.09.029. View

Baylin S, Jones P . A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11(10):726-34. PMC: 3307543. DOI: 10.1038/nrc3130. View

Bui T, Mendell J . Myc: Maestro of MicroRNAs. Genes Cancer. 2010; 1(6):568-575. PMC: 2946068. DOI: 10.1177/1947601910377491. View

Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L . miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 2009; 69(13):5553-9. DOI: 10.1158/0008-5472.CAN-08-4277. View

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H . The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011; 17(2):211-5. PMC: 3076220. DOI: 10.1038/nm.2284. View

Cai K, Bao X, Kong X, Jinag W, Mao M, Chu J . Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int J Mol Med. 2010; 25(4):565-71. DOI: 10.3892/ijmm_00000378. View

10.

Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano H, Yoshikawa K . Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis. 2010; 31(12):2066-73. DOI: 10.1093/carcin/bgq203. View

11.

Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti G, Papotti M . Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010; 8(9):1207-16. DOI: 10.1158/1541-7786.MCR-10-0052. View

12.

Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S . MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009; 69(14):5761-7. DOI: 10.1158/0008-5472.CAN-08-4797. View

13.

Hermeking H . The miR-34 family in cancer and apoptosis. Cell Death Differ. 2009; 17(2):193-9. DOI: 10.1038/cdd.2009.56. View

14.

Rucker F, Russ A, Cocciardi S, Kett H, Schlenk R, Botzenhardt U . Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance. Leukemia. 2012; 27(2):353-61. DOI: 10.1038/leu.2012.208. View

15.

Tian S, Huang S, Wu S, Guo W, Li J, He X . MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region. Biochem Biophys Res Commun. 2010; 396(2):435-9. DOI: 10.1016/j.bbrc.2010.04.112. View

16.

Gallardo E, Navarro A, Vinolas N, Marrades R, Diaz T, Gel B . miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis. 2009; 30(11):1903-9. DOI: 10.1093/carcin/bgp219. View

17.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

18.

Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y . MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med. 2010; 15(9):1887-95. PMC: 3918045. DOI: 10.1111/j.1582-4934.2010.01194.x. View

19.

Park S, Lee J, Ha M, Nam J, Kim V . miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 2008; 16(1):23-9. DOI: 10.1038/nsmb.1533. View

20.

Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, Shibata K . MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol. 2011; 38(5):1437-43. DOI: 10.3892/ijo.2011.969. View